.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Moodys
Daiichi Sankyo
Johnson and Johnson
Citi
AstraZeneca
Farmers Insurance
McKinsey
Novartis
Healthtrust

Generated: June 24, 2017

DrugPatentWatch Database Preview

Technetium tc-99m albumin aggregated kit - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for technetium tc-99m albumin aggregated kit and what is the scope of technetium tc-99m albumin aggregated kit patent protection?

Technetium tc-99m albumin aggregated kit
is the generic ingredient in eight branded drugs marketed by Syncor Pharms, Bracco, Ge Healthcare, Mallinckrodt, Jubilant Draximage, Draximage, and Pharmalucence, and is included in eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m albumin aggregated kit. One supplier is listed for this compound.

Summary for Generic Name: technetium tc-99m albumin aggregated kit

Tradenames:8
Patents:1
Applicants:7
NDAs:8
Drug Master File Entries: see list4
Suppliers / Packagers: see list1
Clinical Trials: see list1,348
Drug Prices:see low prices
DailyMed Link:technetium tc-99m albumin aggregated kit at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Draximage
TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT
technetium tc-99m albumin aggregated kit
INJECTABLE;INJECTION017881-001Dec 30, 1987BSRXNoNo► Subscribe► Subscribe
Mallinckrodt
TECHNESCAN MAA
technetium tc-99m albumin aggregated kit
INJECTABLE;INJECTION017842-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ge Healthcare
LUNGAGGREGATE REAGENT
technetium tc-99m albumin aggregated kit
INJECTABLE;INJECTION017838-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ge Healthcare
TECHNETIUM TC 99M MAA
technetium tc-99m albumin aggregated kit
INJECTABLE;INJECTION017773-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bracco
MACROTEC
technetium tc-99m albumin aggregated kit
INJECTABLE;INJECTION017833-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: technetium tc-99m albumin aggregated kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Draximage
TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT
technetium tc-99m albumin aggregated kit
INJECTABLE;INJECTION017881-001Dec 30, 19873,863,004► Subscribe
Draximage
TECHNETIUM TC 99M ALBUMIN AGGREGATED KIT
technetium tc-99m albumin aggregated kit
INJECTABLE;INJECTION017881-001Dec 30, 19873,872,226► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Citi
Cipla
Baxter
Accenture
Merck
Boehringer Ingelheim
Julphar
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot